Clinical Trial Update: Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating management of antiplatelet drug resistance in patients with drug-eluting coronary stents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Creighton University | Conditions: Coronary Artery Disease | Phase 4 | Status: WITHDRAWN